İsveç piyasaları kapanışta yükseldi; OMX Stockholm 30 0,11% değer kazandı
- YazarInvesting.com
- •
İsim | Son | Taban | Yüksek | Düşük | Fark % | Hac. | Zaman | Fiyat | |
---|---|---|---|---|---|---|---|---|---|
XBRANE Xbrane Biopharma AB | 0,30 | 0,26 | 0,30 | 0,26 | +16,93% | 50,37M | 0,30+16,93% | 31/05 | |
ATORX Alligator Bioscience AB | 1,078 | 0,979 | 1,178 | 0,953 | +10,11% | 7,54M | 1,078+10,11% | 31/05 | |
IMMUN Mendus AB | 0,507 | 0,478 | 0,51 | 0,466 | +6,07% | 3,59M | 0,507+6,07% | 31/05 | |
ONCO Oncopeptides AB | 3,20 | 2,895 | 3,21 | 2,855 | +10,54% | 3,09M | 3,20+10,54% | 31/05 | |
BIOGb Biogaia | 127,80 | 124,20 | 133,00 | 122,40 | +2,90% | 2,01M | 127,80+2,90% | 31/05 |
İsim | Fiyat |
---|---|
XBRANE Xbrane Biopharma | 0,30+0,04+16,93% |
VICOR Vicore Pharma Holding AB | 21,70+2,600+13,61% |
HNSA Hansa Biopharma | 49,80+5,80+13,18% |
CANTA Cantargia AB | 4,80+0,51+11,84% |
ONCO Oncopeptides | 3,20+0,305+10,54% |
İsim | Fiyat |
---|---|
EGTX Egetis Therapeutics AB | 8,08-0,63-7,23% |
CEVI Cellavision | 262,00-17,50-6,26% |
ORX Orexo | 20,00-1,1-5,21% |
SYNACT SynAct Pharma AB | 6,80-0,37-5,09% |
EPISb Episurf Medical AB | 0,27-0,01-3,70% |